Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: 5AM Ventures

JLABS @ Toronto

Thursday, May 3, 2018 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: 5AM Ventures

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info May 2, 2018 CA$15.00 CA$1.90
Volunteer   more info Apr 26, 2018 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: 5AM Ventures

Event Details

Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.

On May 3rd, Jamil Beg and Jason Ruth from 5AM Ventures will present an overview of the firm, it’s investment strategy, primary areas of interest, and a few investment case studies.  Following the presentation, they will meet 1-on-1 with companies that have been accepted after applying online. 

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due April 17th, 2018. Apply Here. 


5AM Ventures is an early stage venture capital fund that partners with academics and entrepreneurs to build the next-generation of life science companies. The firm has been investing in the life sciences for sixteen years and manages approximately $1B USD.  The firm is currently investing it’s fifth fund of $285M USD with a diverse team of experienced drug developers based in Boston and San Francisco.  Through its incubator, 4:59, the team works with founders to seed finance and launch new companies based on innovative discoveries.  The team plays a hands-on role, often taking interim operating roles, to establish companies and move programs forward.  The firm also invests in established companies through Series A investments, primarily leading or co-leading investments. 

Primary area of interest:

The 5AM team is searching for novel technologies with the potential to dramatically improve patient’s lives.  We are stage, modality, and indication agonistic.  The firm has interests in novel discovery platforms and modalities with potential applications across multiple indications.  5AM seeks out opportunities where there is compelling mechanistic rationale through translatable cell & animal models and/or human data supporting the biological approach.

Additional areas:
The firm also makes select investments in therapeutic drug delivery platforms and research tools. Therapeutic drug delivery platforms include novel ways to deliver drugs that are already approved by regulatory agencies with the goals of enhancing efficacy or safety profiles, expanding to novel indications, improving health economics, and ultimately having a significant clinical impact for patients.

To be considered for a 1-on-1 meeting complete the information required here. Applications due by April 17, 2018.

Jamil M. Beg | Principal, 5AM Ventures read bio »
Jason Ruth, PhD | Associate, 5AM Ventures read bio »

10:30AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking Lunch
1:00-5:15 PM | One-on-One Meeting*

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due April 17, 2018. Apply Here.

$15 | General Public

Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 2nd (or sold out). 

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario 

Jamil M. Beg | Principal, 5AM Ventures
Jamil M. Beg joined 5AM Ventures in 2017 as a Principal. Prior to 5AM, Mr. Beg was at Sage Therapeutics (NASDAQ: SAGE) where he contributed to building the company through business development, corporate strategy, medical affairs, health economics & outcomes research and commercialization roles. Prior to Sage, Mr. Beg was an investment professional at Quaker Partners and an operator in several of the firm’s portfolio companies, including EKR Therapeutics (acquired by Cornerstone Therapeutics), Transave Inhalation Therapeutics (acquired by Insmed), NuPathe (NASDAQ: PATH, acquired by Teva) and Cempra (NASDAQ: CEMP). Mr. Beg started his career at Cambridge Pharma Consultancy (acquired by IMS Health) with a focus on pricing, market access and health economics outcomes research strategies for the biopharma industry. Mr. Beg earned his B.S.E. in Bioengineering and Master of Biotechnology degrees from the University of Pennsylvania. He earned his M.B.A. in Healthcare Management and Entrepreneurial Management from The Wharton School of the University of Pennsylvania where he was a recipient of the Henry J. Kaiser Family Foundation Merit Award. Mr. Beg is based in the Boston, MA office.

^ Back to speakers' list ^

Jason Ruth, PhD | Associate, 5AM Ventures
Jason Ruth, Ph.D. joined 5AM Ventures as an Associate in 2017. He was previously a Postdoctoral Fellow at the Broad Institute of MIT and Harvard, where he studied precision medicine and high throughput screening in Levi Garraway’s laboratory as well as started the Broad Institute Biomedical Entrepreneurship course. Dr. Ruth received his Ph.D. in Bioengineering from the University of Pennsylvania as an HHMI-Interfaces Fellow and received a Ruth L. Kirschstein NRSA Predoctoral Fellowship to investigate cancer immunology with Lewis Chodosh. He received a B.S. in Biomedical Engineering from the University of California in Irvine. Dr. Ruth serves as Chief Scientific Officer and as a Scientific Advisory Board member for the Castleman Disease Collaborative Network. His work is published in journals including Science and Lancet Hematology. Dr. Ruth is based in the Boston, MA office.

^ Back to speakers' list ^
Have questions about Investor Spotlight: 5AM Ventures? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where

JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1

Thursday, May 3, 2018 from 10:30 AM to 1:00 PM (EDT)

  Add to my calendar


JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS.

About Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.